Hermann et al. reported that human pancreatic cancer tissue contains CSCs defined by CD133 expression that are exclusively tumorigenic and highly resistant to standard chemotherapy (Hermann et al., 2007). This evidence concerns the gene PROM1 and pancreatic neoplasm.